T. Rowe Price Associates’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,223
| Closed | -$75K | – | 3042 |
|
|
2022
Q1 | $75K | Hold |
8,223
| – | – | ﹤0.01% | 2887 |
|
|
2021
Q4 | $177K | Sell |
8,223
-417
| -5% | -$11.2K | ﹤0.01% | 2786 |
|
|
2021
Q3 | $283K | Hold |
8,640
| – | – | ﹤0.01% | 2605 |
|
|
2021
Q2 | $360K | Buy |
8,640
+3,128
| +57% | +$160K | ﹤0.01% | 2525 |
|
|
2021
Q1 | $360K | Buy |
5,512
+239
| +5% | +$16.7K | ﹤0.01% | 2504 |
|
|
2020
Q4 | $346K | Sell |
5,273
-3
| -0.1% | -$196 | ﹤0.01% | 2379 |
|
|
2020
Q3 | $287K | Buy |
5,276
+2,607
| +98% | +$199K | ﹤0.01% | 2302 |
|
|
2020
Q2 | $255K | Sell |
2,669
-864
| -24% | -$64.4K | ﹤0.01% | 2291 |
|
|
2020
Q1 | $181K | Buy |
3,533
+594
| +20% | +$62.1K | ﹤0.01% | 2335 |
|
|
2019
Q4 | $242K | Buy |
2,939
+75
| +3% | +$5.26K | ﹤0.01% | 2374 |
|
|
2019
Q3 | $245K | Buy |
2,864
+10
| +0.4% | +$1.07K | ﹤0.01% | 2352 |
|
|
2019
Q2 | $364K | Buy |
2,854
+4
| +0.1% | +$576 | ﹤0.01% | 2243 |
|
|
2019
Q1 | $514K | Buy |
2,850
+3
| +0.1% | +$434 | ﹤0.01% | 2100 |
|
|
2018
Q4 | $316K | Sell |
2,847
-1
| -0% | -$130 | ﹤0.01% | 2263 |
|
|
2018
Q3 | $384K | Hold |
2,848
| – | – | ﹤0.01% | 2257 |
|
|
2018
Q2 | $393K | Buy |
2,848
+2
| +0.1% | +$275 | ﹤0.01% | 2249 |
|
|
2018
Q1 | $393K | Buy |
2,846
+4
| +0.1% | +$544 | ﹤0.01% | 2178 |
|
|
2017
Q4 | $350K | Sell |
2,842
-83
| -3% | -$11.4K | ﹤0.01% | 2224 |
|
|
2017
Q3 | $399K | Hold |
2,925
| – | – | ﹤0.01% | 2175 |
|
|
2017
Q2 | $513K | Hold |
2,925
| – | – | ﹤0.01% | 2056 |
|
|
2017
Q1 | $351K | Buy |
2,925
+2
| +0.1% | +$208 | ﹤0.01% | 2191 |
|
|
2016
Q4 | $285K | Hold |
2,923
| – | – | ﹤0.01% | 2272 |
|
|
2016
Q3 | $275K | Hold |
2,923
| – | – | ﹤0.01% | 2255 |
|
|
2016
Q2 | $315K | Hold |
2,923
| – | – | ﹤0.01% | 2143 |
|
|
2016
Q1 | $351K | Hold |
2,923
| – | – | ﹤0.01% | 2104 |
|
|
2015
Q4 | $348K | Buy |
2,923
+3
| +0.1% | +$387 | ﹤0.01% | 2102 |
|
|
2015
Q3 | $498K | Hold |
2,920
| – | – | ﹤0.01% | 1947 |
|
|
2015
Q2 | $566K | Hold |
2,920
| – | – | ﹤0.01% | 1948 |
|
|
2015
Q1 | $433K | Sell |
2,920
-183
| -6% | -$27.9K | ﹤0.01% | 2039 |
|
|
2014
Q4 | $484K | Sell |
3,103
-64
| -2% | -$9.22K | ﹤0.01% | 1967 |
|
|
2014
Q3 | $454K | Hold |
3,167
| – | – | ﹤0.01% | 1980 |
|
|
2014
Q2 | $413K | Buy |
3,167
+100
| +3% | +$12.7K | ﹤0.01% | 2029 |
|
|
2014
Q1 | $375K | Hold |
3,067
| – | – | ﹤0.01% | 2040 |
|
|
2013
Q4 | $326K | Buy |
3,067
+334
| +12% | +$32.4K | ﹤0.01% | 2104 |
|
|
2013
Q3 | $307K | Buy |
2,733
+666
| +32% | +$75.6K | ﹤0.01% | 2107 |
|
|
2013
Q2 | $233K | Buy |
+2,067
| New | +$253K | ﹤0.01% | 2159 |
|
Other funds holding SRGA
AWS
CLG
T. Rowe Price Associates's SRGA Position: Q2 2022 in Review
T. Rowe Price Associates sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 8,223 shares — an estimated $75K sold.
T. Rowe Price Associates first reported a position in SRGA in Q2 2013 and held it in 36 quarters. The position peaked at $566K in Q2 2015. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.
- T. Rowe Price Associates reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 8,223 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $75K.
- T. Rowe Price Associates first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- T. Rowe Price Associates's Surgalign Holdings, Inc. Common Stock position peaked at $566K in Q2 2015.
- 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.